The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.
However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on Microbiome vs probiotics and the link between them.
Connect with biotech, pharma, academicians and investors at 4th Annual Next Gen Microbiome and Probiotics Conference on 3-4 February 2022 in San Diego, USA, discussing the most ingenious research and technological advances. Key sessions on Applying new microbiome findings, regulatory updates, brandng and marketing of probiotics along with discussion on effective translation from R& D to commercialization.
Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of: